SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Myriad Genetics, Inc. (MYGN)
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
2355 65 0 MYGN
Emcee:  s myers Type:  Unmoderated
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1855Deleted...EOMsim1-3/26/2006
1854To be sorted into the file marked: "Noted, but don't understand why&quoIcebrg-3/24/2006
1853not strange, the wires work that way, someone issues a PR and each decides to prmopgcw-3/24/2006
1852Not really. I think it's public spirited journalism. What I do think is strtom pope-3/23/2006
1851Anyone find it strange that the articles were in both NY Times and WSJ at the saRobohogs-3/23/2006
1850Myriad flays media claims Reports that breast cancer test is flawed are false, cmopgcw-3/23/2006
1849Myriad Genetics Dips on Article, Study Wednesday March 22, 3:34 pm ET Myriad Gmopgcw-3/23/2006
1848Thanks Rick!..here's a patent I found that the US is selling..think we can gzeta1961-3/23/2006
1847zeta stuff..... Proc Natl Acad Sci U S A. 2006 Mar 20; [Epub ahead of print] Iscaram(o)uche-3/22/2006
1846Stupid way to start the day (WSJ): Test for Breast-Cancer Risk Could Miss Mark tom pope-3/22/2006
1845thestreet.com Myriad Genetics rated new Buy at UBS: UBS said it is reinstating scaram(o)uche-3/17/2006
1844Anyone here know this guy? Worth making the effort? pubaffairs.ucsf.edu Thankszeta1961-3/13/2006
1843I thought it interesting too. But I saw the PR as a CEGE release and I do know tzeta1961-3/13/2006
1842I suppose it is the Cell Genesys' PR this morning you are referring to. I thIcebrg-3/13/2006
1841Correction: place holders are also in there since December <i>ASCO abstrazeta1961-3/13/2006
1840No argument there re: ASCO pr's, in principle..I do wish there was an establzeta1961-3/13/2006
1839Sorry, I didn't put on my Rick lense/filter this morning.. <i>it'zeta1961-3/13/2006
1838>> 34 << moose at yahoo says it's 32, not 34. thanks, moose.scaram(o)uche-3/13/2006
1837>> Come on, Rick..ya' think it's less tacky to tell shareholders 3scaram(o)uche-3/13/2006
1836"pulled out" was not a reference to weeding out a patient from inclusiscaram(o)uche-3/13/2006
1835edit: never thought of this before..could flurbie turn out like the novel cancerzeta1961-3/13/2006
1834Thanks, Rick. Maybe they should have labeled it the "how-we-like -to-look-atticus4paws-3/13/2006
1833someone paid $34/share at the beginning of pre-market trading today.scaram(o)uche-3/13/2006
1832<i>we are measuring the difference between the slopes of the treated groupscaram(o)uche-3/13/2006
1831Ok. So what's the take here? You guys have bashed Flurizan (or maybe the tatticus4paws-3/13/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):